Karen Linehan
Direktor/Vorstandsmitglied bei VEON LTD.
Vermögen: 135 456 $ am 30.04.2024
Aktive Positionen von Karen Linehan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VEON LTD. | Direktor/Vorstandsmitglied | 04.01.2022 | - |
Independent Dir/Board Member | 04.01.2022 | - | |
AELIS FARMA | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Independent Dir/Board Member | 01.01.2022 | - | |
CNH INDUSTRIAL N.V. | Direktor/Vorstandsmitglied | 11.03.2022 | - |
Independent Dir/Board Member | 11.03.2022 | - | |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Direktor/Vorstandsmitglied | - | - |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Direktor/Vorstandsmitglied | - | - |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Direktor/Vorstandsmitglied | - | - |
Georgetown University Law Center | Corporate Officer/Principal | - | - |
Karriereverlauf von Karen Linehan
Ehemalige bekannte Positionen von Karen Linehan
Ausbildung von Karen Linehan
Georgetown University | Graduate Degree |
Statistik
International
Frankreich | 4 |
Vereinigte Staaten | 3 |
Deutschland | 3 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Communications | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
SANOFI | Health Technology |
VEON LTD. | Communications |
AELIS FARMA | Health Technology |
CNH INDUSTRIAL N.V. | Producer Manufacturing |
EUROAPI | Health Technology |
Private Unternehmen | 3 |
---|---|
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Health Technology |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Health Technology |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Health Technology |
- Börse
- Insiders
- Karen Linehan
- Erfahrung